ENDEAVOR RX
Report
- Report Number
- 9612164-2018-00556
- Event Type
- Death
- Date Received
- March 26, 2018
- Date of Event
- January 1, 2018
- Report Date
- March 26, 2018
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
LITERATURE ARTICLE TITLE: SHORT-TERM VERSUS LONG-TERM DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENT IMPLANTATION IN ELDERLY PATIENTS A META-ANALYSIS OF INDIVIDUAL PARTICIPANT DATA FROM 6 RANDOMIZED TRIALS. AUTHORS: SEUNG-YUL LEE, MD, MYEONG-KI HONG, MD, PHD, TULLIO PALMERINI, MD, HYO-SOO KIM, MD, MARCO VALGIMIGLI, MD, FAUSTO FERES, MD, ANTONIO COLOMBO, MD, MARTINE GILARD, MD, DONG-HO SHIN, MD, JUNG-SUN KIM, MD, BYEONG-KEUK KIM, MD, YOUNG-GUK KO, MD, DONGHOON CHOI, MD, YANGSOO JANG, MD, GREGG W. STONE, MD JOURNAL NAME: J A C C : CARDIOVASCULAR INTERVENTIONS D O I . O R G / 1 0 . 1 0 1 6 / J . J C ENDEAVOR RX NOT APPROVED IN THE USA BUT IS SIMILAR TO ENDEAVOUR SPRINT RX. ENDEAVOUR SPRINT RX IS APPROVED FOR IN THE USA. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
THIS STUDY WAS TO EVALUATE THE OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY (DAPT) AFTER THE IMPLANTATION OF DRUG-ELUTING STENT (DES) IN ELDERLY PATIENTS. ENDEAVOR ZOTAROLIMUS-ELUTING STENTS WERE IMPLANTED IN THE LEFT MAIN, LEFT ANTERIOR DESCENDING ARTERY, LEFT CIRCUMFLEX ARTERY AND RIGHT CORONARY ARTERY. AT 6 MONTHS AND 12 MONTHS FOLLOW UP, THE FOLLOWING CLINICAL OUTCOMES WERE REPORTED - CARDIAC AND NON-CARDIAC DEATHS, MYOCARDIAL INFARCTION, DEFINITE OR PROBABLE STENT THROMBOSIS, STROKE AND BLEEDING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 214478 | ENDEAVOR RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Death |